Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octagam 10% phase 3 trial in active dermatomyositis
NL-OMON46776Phase 3Active, not recruiting
- Sponsor
- Octapharma
- Start
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of Human normal immunoglobulin G, sponsored by Octapharma. Started Jul 2018; status: active, not recruiting.
02
Drugs
Human normal immunoglobulin G
Beyond the preview
Go deeper on NL-OMON46776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46776.